News
Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...
Despite recent challenges ranging from wildfires to economic uncertainty, Los Angeles remains a prime destination, not only ...
Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology company that launched nearly two decades ago with plans to make drugs capable of targeting small ...
This collaboration will provide early-stage HER2-positive breast cancer patients with access to the targeted therapy that can reduce the risk of cancer recurrence and spread ATHENS, Greece and LOS ...
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today it will support biotech innovator ... continuously remanufactured into new products without degradation in quality ...
With a focus on commercialization, Thurlow brings deep experience launching new products and technologies, creating customer partnerships, building teams and driving revenue growth. Throughout his ...
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and ...
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development ...
Biotech startup creator Versant Ventures is among them ... clinical testing. Granite is a product of Ridgeline Therapeutics, part of an initiative Versant hatched more than a decade ago to help turn ...
Led by Professor Rupa Iyer, the biotechnology program features new state-of-the ... strategies and successful commercialization of ideas. His class, Innovation and Opportunity Development, is a new ...
Students will explore the use of a technology through a new biotech company, experiencing the translation process of converting a lab technology to a practical product used in daily life. The Arany ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results